Otolaryngology - Head & Neck Surgery Supplement - 2020 Official Program Abstracts - P42

P42
Otolaryngology-Head and Neck Surgery 163(1S)
Presentation schedule is subject to change.The Official Program Abstracts supplement does not reflect changes made after August 10, 2020.

Rhinology/Allergy

The role of allergy in diseases such as Eustachian tube dysfunction, chronic otitis media, Ménière's disease, obstructive
sleep apnea, chronic cough, laryngitis, chronic sinusitis, and
oral allergy syndrome will be discussed by experts in each
individual field. The pathophysiology, clinical features, and
treatment options will be reviewed. The learner will leave the
session with a more comprehensive understanding of the
impact and manifestations of allergic disease throughout the
head and neck.
Outcome Objectives: (1) Define the role of allergic disease in
the pathophysiology of the head and neck. (2) Explain the role
of allergy testing in head and neck diseases other than allergic
rhinitis. (3) Describe the role of allergy treatment in the management of diseases of the head and neck other than allergic
rhinitis.
Balloon Sinus Dilation: Indications,
Technique, and Evidence
Waleed M. Abuzeid, MD (Moderator); Satish Govindaraj, MD;
Spencer C. Payne, MD; Michael Setzen, MD
Session Description: Balloon sinus dilation involves the use
of catheter-based devices to dilate sinus ostia with the goal of
improving the ventilation and drainage of diseased sinuses in
the treatment of a variety of inflammatory sinus disease
pathologies. Although increasingly popular, there remains
debate regarding the efficacy of this technique in the setting of
an expanding body of literature. Furthermore, there is increasing concern regarding the potential over use of this technology.
Consequently, the American Academy of Otolaryngology-
Head and Neck Surgery issued a Consensus Statement on
Balloon Sinus Dilation in 2017 to ensure patient safety and
proper utilization. This session will engage attendees in an
evidence-based discussion regarding the indications, contraindications, and outcomes for balloon sinus dilation in the operating room and office setting. Attendees will enhance their
understanding of the primary findings, conclusions, and limitations of the scientific literature as it relates to balloon sinus
dilation and as viewed from the perspectives of the panel
members. Attendees will gain insight into the controversy surrounding potential overuse and abuse of balloon sinus dilation. Attendees will also gain practical knowledge pertaining
to the successful use of balloon sinus dilation-as well as possible complications directly related to the use of this technology. The panelists are experts in advanced rhinology both
from academic and private practice environments and all have
significant experience and varied views on balloon sinus dilation, which should be informative and engaging for session
attendees.
Outcome Objectives: (1) Understand the indications, contraindications, techniques, and outcomes for balloon sinus dilation. (2) Discuss the primary findings, conclusions, and
limitations of the scientific literature related to balloon sinus
dilation. (3) Review the evidence underlying claims of overuse of this technology and the factors that may influence physician utilization.

Controversies in the Contemporary
Management of Nasal and Sinus Disease
Rakesh K. Chandra, MD (Moderator); Raj Sindwani, MD, FRCSC;
Pete S. Batra, MD; Joseph K. Han, MD
Session Description: The past decade has hallmarked considerable evolution in the management of nasal and sinus disease.
This has emerged from a proliferation in technology, mounting
clinical experience, clinical and translational evidence, and a
better understanding of the physiologic basis of many nasal
and sinus disorders. Simultaneously, socioeconomic pressures
have affected practice patterns. The cumulative effect of these
forces has led to many novel and alternative therapeutic pathways in the management of various sinonasal conditions.
Consequently, this has also led to many controversies regarding what constitutes best practice with regard to patient satisfaction, objective outcomes, and economic value. The panel
comprises an experienced and diverse group of fellowshiptrained rhinologists who will examine these controversies,
largely using a case-based format in which each given case will
highlight 1 or more particular points of controversy. Potential
topics to be explored include surgery in the office vs an ambulatory surgery center vs a hospital operating room, balloon
sinuplasty vs conventional functional endoscopic sinus surgery, what constitutes maximum medical therapy, the role of
surgery for headaches, the value of nasal or sinus surgery in
sleep apnea, pain management in sinonasal surgery, and use of
biologics in chronic rhinosinusitis. The discussion will include
a mixture of evidence-based recommendations, expert opinion,
and current practice guidelines. We will also address how these
cases may have been handled in the past and how the current
environment has shaped practice.
Outcome Objectives: (1) Identify areas of variation in practice patterns in the management of nasal and sinus disease. (2)
Explore how the proliferation of treatment options has led to
controversies in medical decision making. (3) Apply evidence,
expert opinion, and current treatment guidelines to promote
best subjective and objective outcomes.
FESS, Biologics, and Biomarkers, Oh My! A
Case-Based Approach to Decision Making
for Nasal Polyposis
Christine Blanche Franzese, MD (Moderator); Cecelia
Damask, DO; Sarah K. Wise, MD, MSCR; Stella E. Lee, MD
Session Description: Chronic sinusitis with nasal polyposis
(CRSwNP) is becoming more widely recognized as a type 2
inflammatory disease, but the best treatment strategies for personalized patient treatment and which biomarkers to use to
predict treatment success are still being investigated. For some
patients, a complete functional endoscopic sinus surgery
(FESS) followed by medical therapy is successful at controlling disease recurrence. For others, this is not the case, and
they sometimes require numerous additional surgeries to control the burden of disease. With the advent of Food and Drug
Administration-approved biologics for nasal polyps and

Otolaryngology - Head & Neck Surgery Supplement - 2020 Official Program Abstracts

Table of Contents for the Digital Edition of Otolaryngology - Head & Neck Surgery Supplement - 2020 Official Program Abstracts